Informed-money record

NAMS · NewAmsterdam Pharma Company N.V.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

Bearish filings

Named actors

Disclosed $ (bull / bear)

$47K / $355.4M

Recent disclosures

25 of 77 in the window · linked to source

Date	Who	What	Disclosed $	Receipt
2026-08-25	Affiliate (via J.P. Morgan Securities LLC) Kastelein Johannes Jacob Pieter	filed notice to sell	$7.0M	SEC ↗
2026-08-24	Chief Scientific Officer Kastelein Johannes Jacob Pieter	sold	$3.4M	SEC ↗
2026-08-24	Affiliate (via J.P. Morgan Securities LLC) Kastelein Johannes Jacob Pieter	filed notice to sell	$3.5M	SEC ↗
2026-07-20	Chief Accounting Officer Kooij Louise Frederika	sold	$2.1M	SEC ↗
2026-07-20	Chief Accounting Officer Kooij Louise Frederika	sold	$990K

52 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →

Dispute or correct this record

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals